Abstract

Myofibroblast differentiation plays an important role in the malignant progression of phyllodes tumor, a fast-growing neoplasm derived from periductal stromal cells of the breast. Macrophages are frequently found in close proximity with myofibroblasts, but it is uncertain whether they are involved in the myofibroblast differentiation during phyllodes tumor progression. Here we show that increased density of tumor-associated macrophage (TAM) correlates with malignant progression of phyllodes tumor. We found that TAMs stimulated myofibroblast differentiation and promoted the proliferation and invasion of phyllodes tumor cells. Furthermore, we found that levels of the chemokine CCL18 in TAM was an independent prognostic factor of phyllodes tumor. Mechanistic investigations showed that CCL18 promoted expression of α-smooth muscle actin, a hallmark of myofibroblast, along with the proliferation and invasion of phyllodes tumor cells, and that CCL18-driven myofibroblast differentiation was mediated by an NF-κB/miR-21/PTEN/AKT signaling axis. In murine xenograft models of human phyllodes tumor, CCL18 accelerated tumor growth, induced myofibroblast differentiation, and promoted metastasis. Taken together, our findings indicated that TAM drives myofibroblast differentiation and malignant progression of phyllodes tumor through a CCL18-driven signaling cascade amenable to antibody disruption. Cancer Res; 77(13); 3605-18. ©2017 AACR.

Highlights

  • Breast phyllodes tumor is a biphasic breast tumor composed of cellular spindle stroma with epithelial elements

  • To investigate whether malignant progression of phyllodes tumor is correlated with tumor-associated macrophage (TAM) density, we examined the presence of TAMs in 268 phyllodes tumor samples, including 167 benign, 36 borderline, and 65 malignant phyllodes tumors

  • As we have found TAM density is correlated with malignant progression of phyllodes tumors and our previous studies have reported that myofibroblast differentiation is associated with the malignant progression of phyllodes tumors [4], we speculated that TAMs may play an important role in the myofibroblast differentiation of breast phyllodes tumors

Read more

Summary

Introduction

Breast phyllodes tumor is a biphasic breast tumor composed of cellular spindle stroma with epithelial elements. It constitutes 0.3% to 1% of all breast tumors and 2.5% of fibroepithelial lesions of the breast [1]. Phyllodes tumors are histologically classified as benign, borderline, or malignant on the basis of stromal cellularity, mitotic activity of stromal cells, stromal nuclear atypia, stromal overgrowth, and types of border (infiltrating or pushing). Adjuvant chemotherapy or radiotherapy is not effective against phyllodes tumors [2]. The potentially recurring and metastatic behavior of phyllodes tumors is attributed to the characteristics of stromal cells, mainly fibroblasts [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call